Biomea Fusion, Inc.

BMEA · Nasdaq · SIC 2834: Pharmaceutical Preparations
104
SEC Filings

Business Summary

5 Item 1A. Risk Factors 26 Item 1B. Unresolved Staff Comments 83 Item 1C. Cybersecurity 83 Item 2. Properties 83 Item 3. Legal Proceedings 84 Item 4. Mine Safety Disclosures 84 PART II Item 5. Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 85 Item 6. Selected Financial Data 85 Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations 85 Item 7A. Quantitative and Qualitative Disclosures About Market Ri...

Next Earnings

Q2 FY2026 — expected 2026-08-14

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionBMEAdiscussed_in_filing Cybersecurity
topic_mentionBMEAdiscussed_in_filing Cybersecurity
topic_mentionBMEAdiscussed_in_filing Cybersecurity
topic_mentionBMEAdiscussed_in_filing Cybersecurity

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-242025-12-310001193125-26-121825EDGAR90K words
2025-03-312024-12-310000950170-25-047775EDGAR—
2024-03-282023-12-310000950170-24-038026EDGAR—
2023-03-282022-12-310000950170-23-010312EDGAR—
2022-02-282021-12-310001564590-22-007624EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-042025-09-300001193125-25-264679EDGAR66K words
2025-08-052025-06-300000950170-25-103041EDGAR—
2025-05-052025-03-310000950170-25-063543EDGAR—
2024-10-292024-09-300000950170-24-118366EDGAR—
2024-07-312024-06-300000950170-24-088584EDGAR—
2024-05-022024-03-310000950170-24-052082EDGAR—
2023-10-302023-09-300000950170-23-056381EDGAR—
2023-07-312023-06-300000950170-23-035946EDGAR—
2023-05-022023-03-310000950170-23-016700EDGAR—
2022-11-072022-09-300000950170-22-022607EDGAR—
2022-08-012022-06-300000950170-22-013678EDGAR—
2022-05-162022-03-310000950170-22-009947EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-240001193125-26-121811EDGAR2K words
2026-02-250001193125-26-068375EDGAR—
2026-01-140001193125-26-012908EDGAR—
2025-11-040001193125-25-264631EDGAR—
2025-10-070001193125-25-233614EDGAR—
2025-10-060001193125-25-231903EDGAR—
2025-08-050000950170-25-103023EDGAR—
2025-07-240001193125-25-163815EDGAR—
2025-06-200001193125-25-143747EDGAR—
2025-06-180001193125-25-142830EDGAR—

104 total filings indexed. 77 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001840439
TickerBMEA
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 7ecdc26d2b5dfc3adc24b9bc160a0c7a6eeb1cee0b05714eb0bb6598bcf75b5f
parent: 9eee9aaf02d52bd72e3e620d440ee604ac7535ade084d557562319e04e1ad298
content hash: 7ebdcdb45311cbf965904199b71502c79b928e7bb23b694952856138de1e379b
signed: 2026-04-13T04:44:01.786Z
sources: 17 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf